Roles
- Associate Professor Clinical Neurology
-
Education & Training
Education
-
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
Determining Brain Death: Neurology Residents Gain Critical Insight into a Complex Process
Miller School Inducts AOA, Gold Humanism Honor Society Members
Florida Stroke Registry Researchers Study Haitian Creole Translation for Stroke Awareness Tool
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 3 clinical trials.
-
The purpose of this research study is to see if a medicine used to treat and prevent bleeding improves outcomes after a stroke caused by bleeding in the brain. The medicine is called Recombinant Factor VIIa. Participants in this study will receive either the medicine or a placebo that contains no active medications. This is a research study, and the use of the medicine is not approved by the U.S. Food and Drug Administration as it is being used in this study.
- Principal Investigator: Erika Marulanda-Londono
- Study Phase: TBD
- Enrollment Status: Open
-
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)
- Principal Investigator: Erika Marulanda-Londono
- Study Phase: Phase 3
- Enrollment Status: Closed
-
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
- Principal Investigator: Erika Marulanda-Londono
- Study Phase: Phase 3
- Enrollment Status: Closed